507 related articles for article (PubMed ID: 25582131)
1. Hyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: therapeutic effect in rabbit Vx2 tumours.
Staruch RM; Hynynen K; Chopra R
Int J Hyperthermia; 2015 Mar; 31(2):118-33. PubMed ID: 25582131
[TBL] [Abstract][Full Text] [Related]
2. Interleaved Mapping of Temperature and Longitudinal Relaxation Rate to Monitor Drug Delivery During Magnetic Resonance-Guided High-Intensity Focused Ultrasound-Induced Hyperthermia.
Kneepkens E; Heijman E; Keupp J; Weiss S; Nicolay K; Grüll H
Invest Radiol; 2017 Oct; 52(10):620-630. PubMed ID: 28598900
[TBL] [Abstract][Full Text] [Related]
3. Enhanced drug delivery in rabbit VX2 tumours using thermosensitive liposomes and MRI-controlled focused ultrasound hyperthermia.
Staruch RM; Ganguly M; Tannock IF; Hynynen K; Chopra R
Int J Hyperthermia; 2012; 28(8):776-87. PubMed ID: 23153219
[TBL] [Abstract][Full Text] [Related]
4. Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery.
Partanen A; Yarmolenko PS; Viitala A; Appanaboyina S; Haemmerich D; Ranjan A; Jacobs G; Woods D; Enholm J; Wood BJ; Dreher MR
Int J Hyperthermia; 2012; 28(4):320-36. PubMed ID: 22621734
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin.
de Smet M; Hijnen NM; Langereis S; Elevelt A; Heijman E; Dubois L; Lambin P; Grüll H
Invest Radiol; 2013 Jun; 48(6):395-405. PubMed ID: 23399809
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and hyperthermic release of doxorubicin from liposomal doxorubicin hydrochloride in rabbit VX2 tumours.
Xiong P; Ding A; Su Z; Shen G; Chen Y; Zhang S
Int J Hyperthermia; 2015; 31(8):900-8. PubMed ID: 26726929
[TBL] [Abstract][Full Text] [Related]
7. Longer heating duration increases localized doxorubicin deposition and therapeutic index in Vx2 tumors using MR-HIFU mild hyperthermia and thermosensitive liposomal doxorubicin.
Bing C; Patel P; Staruch RM; Shaikh S; Nofiele J; Wodzak Staruch M; Szczepanski D; Williams NS; Laetsch T; Chopra R
Int J Hyperthermia; 2019; 36(1):196-203. PubMed ID: 30541350
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model.
Wijlemans JW; Deckers R; van den Bosch MA; Seinstra BA; van Stralen M; van Diest PJ; Moonen CT; Bartels LW
Invest Radiol; 2013 Jun; 48(6):381-6. PubMed ID: 23399810
[TBL] [Abstract][Full Text] [Related]
9. Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound.
Hijnen N; Kneepkens E; de Smet M; Langereis S; Heijman E; Grüll H
Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4802-E4811. PubMed ID: 28566498
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermia in bone generated with MR imaging-controlled focused ultrasound: control strategies and drug delivery.
Staruch R; Chopra R; Hynynen K
Radiology; 2012 Apr; 263(1):117-27. PubMed ID: 22438444
[TBL] [Abstract][Full Text] [Related]
11. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model.
Ranjan A; Jacobs GC; Woods DL; Negussie AH; Partanen A; Yarmolenko PS; Gacchina CE; Sharma KV; Frenkel V; Wood BJ; Dreher MR
J Control Release; 2012 Mar; 158(3):487-94. PubMed ID: 22210162
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model.
Sebeke LC; Castillo Gómez JD; Heijman E; Rademann P; Simon AC; Ekdawi S; Vlachakis S; Toker D; Mink BL; Schubert-Quecke C; Yeo SY; Schmidt P; Lucas C; Brodesser S; Hossann M; Lindner LH; Grüll H
J Control Release; 2022 Mar; 343():798-812. PubMed ID: 35134460
[TBL] [Abstract][Full Text] [Related]
13. High-intensity focused ultrasound-induced, localized mild hyperthermia to enhance anti-cancer efficacy of systemic doxorubicin: an experimental study.
Chae SY; Kim YS; Park MJ; Yang J; Park H; Namgung MS; Rhim H; Lim HK
Ultrasound Med Biol; 2014 Jul; 40(7):1554-63. PubMed ID: 24642222
[TBL] [Abstract][Full Text] [Related]
14. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.
Lyon PC; Gray MD; Mannaris C; Folkes LK; Stratford M; Campo L; Chung DYF; Scott S; Anderson M; Goldin R; Carlisle R; Wu F; Middleton MR; Gleeson FV; Coussios CC
Lancet Oncol; 2018 Aug; 19(8):1027-1039. PubMed ID: 30001990
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance-Guided High-Intensity Focused Ultrasound Hyperthermia for Recurrent Rectal Cancer: MR Thermometry Evaluation and Preclinical Validation.
Chu W; Staruch RM; Pichardo S; Tillander M; Köhler MO; Huang Y; Ylihautala M; McGuffin M; Czarnota G; Hynynen K
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1259-67. PubMed ID: 27209510
[TBL] [Abstract][Full Text] [Related]
16. The effect of injected dose on localized tumor accumulation and cardiac uptake of doxorubicin in a Vx2 rabbit tumor model using MR-HIFU mild hyperthermia and thermosensitive liposomes.
Cheng B; Bing C; Staruch RM; Shaikh S; Wodzak Staruch M; Szczepanski D; Williams NS; Laetsch TW; Chopra R
Int J Hyperthermia; 2020; 37(1):1052-1059. PubMed ID: 32892667
[TBL] [Abstract][Full Text] [Related]
17. Drift correction for accurate PRF-shift MR thermometry during mild hyperthermia treatments with MR-HIFU.
Bing C; Staruch RM; Tillander M; Köhler MO; Mougenot C; Ylihautala M; Laetsch TW; Chopra R
Int J Hyperthermia; 2016 Sep; 32(6):673-87. PubMed ID: 27210733
[TBL] [Abstract][Full Text] [Related]
18. Localised drug release using MRI-controlled focused ultrasound hyperthermia.
Staruch R; Chopra R; Hynynen K
Int J Hyperthermia; 2011; 27(2):156-71. PubMed ID: 21158487
[TBL] [Abstract][Full Text] [Related]
19. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.
Gasselhuber A; Dreher MR; Partanen A; Yarmolenko PS; Woods D; Wood BJ; Haemmerich D
Int J Hyperthermia; 2012; 28(4):337-48. PubMed ID: 22621735
[TBL] [Abstract][Full Text] [Related]
20. Iron(III)-Based Magnetic Resonance-Imageable Liposomal T1 Contrast Agent for Monitoring Temperature-Induced Image-Guided Drug Delivery.
Kneepkens E; Fernandes A; Nicolay K; Grüll H
Invest Radiol; 2016 Nov; 51(11):735-745. PubMed ID: 27309776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
